Concurrent Investment Advisors, LLC Novartis Ag Transaction History
Concurrent Investment Advisors, LLC
- $4.12 Trillion
- Q1 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 5,795 shares of NVS stock, worth $657,674. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,795
Previous 4,143
39.87%
Holding current value
$657,674
Previous $403 Million
60.27%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,505Shares Held
129MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.25 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$929 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$780 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$633 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...